Flagship Harbor Advisors LLC Has $209,000 Stake in Tenet Healthcare Co. (NYSE:THC)

Flagship Harbor Advisors LLC raised its holdings in Tenet Healthcare Co. (NYSE:THC) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,655 shares of the company’s stock after buying an additional 285 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in Tenet Healthcare were worth $209,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Impact Partnership Wealth LLC acquired a new stake in Tenet Healthcare in the 4th quarter worth $338,000. Inspire Investing LLC grew its position in Tenet Healthcare by 25.6% during the fourth quarter. Inspire Investing LLC now owns 6,496 shares of the company’s stock worth $820,000 after buying an additional 1,326 shares in the last quarter. SG Americas Securities LLC raised its holdings in Tenet Healthcare by 81.9% in the 4th quarter. SG Americas Securities LLC now owns 8,077 shares of the company’s stock valued at $1,020,000 after acquiring an additional 3,637 shares in the last quarter. Crossmark Global Holdings Inc. grew its holdings in shares of Tenet Healthcare by 41.1% during the 4th quarter. Crossmark Global Holdings Inc. now owns 8,731 shares of the company’s stock worth $1,102,000 after purchasing an additional 2,544 shares in the last quarter. Finally, Wedge Capital Management L L P NC raised its stake in shares of Tenet Healthcare by 3.1% in the fourth quarter. Wedge Capital Management L L P NC now owns 238,465 shares of the company’s stock valued at $30,101,000 after purchasing an additional 7,112 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $143.27 on Friday. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. Tenet Healthcare Co. has a 52 week low of $82.15 and a 52 week high of $171.20. The firm has a fifty day moving average of $134.04 and a two-hundred day moving average of $148.20. The stock has a market capitalization of $13.62 billion, a price-to-earnings ratio of 4.59, a PEG ratio of 0.60 and a beta of 2.06.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.33 by $0.60. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.05 billion. During the same period in the previous year, the company earned $1.44 EPS. The company’s revenue for the quarter was up 1.1% compared to the same quarter last year. As a group, equities research analysts predict that Tenet Healthcare Co. will post 11.37 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on THC shares. StockNews.com lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 17th. Cantor Fitzgerald increased their price target on shares of Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. Raymond James lowered Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a research note on Friday, November 22nd. UBS Group raised their target price on Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada increased their price objective on Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $165.00.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.